Febrile seizures after 2010-2011 influenza vaccine in young children, United States: A vaccine safety signal from the vaccine adverse event reporting system

Vaccine

Volumn 30, Issue 11, 2012, Pages 2020-2023

  Leroy, Z ^a   Broder, K ^a   Menschik, D ^b   Shimabukuro, T ^a   Martin, D ^b  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

Febrile seizure; Post marketing surveillance; Trivalent influenza vaccine; Vaccine safety

Indexed keywords

INFLUENZA VACCINE;

ARTICLE; CLINICAL FEATURE; DATA MINING; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; FEBRILE CONVULSION; HUMAN; INFANT; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE;

ADVERSE DRUG REACTION REPORTING SYSTEMS; BAYES THEOREM; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); CHILD, PRESCHOOL; DATA MINING; FEMALE; HUMANS; INFANT; INFLUENZA VACCINES; MALE; PRODUCT SURVEILLANCE, POSTMARKETING; SEIZURES, FEBRILE; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84857181341     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.12.042     Document Type: Article

References (20)

1. Varricchio F., Iskander J., Destefano F., Ball R., Pless R., Braun M.M., et al. Understanding vaccine safety information from the Vaccine Adverse Event Reporting System. Pediatr Infect Dis J 2004, 23:287-294.
2. Vellozzi C., Burwen D., Dobardzic A., Ball R., Walton K., Haber P. Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring. Vaccine 2009, 27:2114-2120.
3. Vellozzi C., Broder K., Haber P. Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010. Vaccine 2010, 28:7248-7255.
4. Blyth C.C., Currie A.J., Wiertsema S.P., Conway N., Kirkham L.A., Fuery A., et al. Trivalent influenza vaccine and febrile adverse events in Australia, 2010: clinical features and potential mechanisms. Vaccine 2011, 29(32):5107-5113.
5. Investigation into febrile reactions in young children following 2010 seasonal trivalent influenza vaccination. Available at http://www.tga.gov.au/pdf/alerts-medicine-seasonal-flu-100702.pdf.
6. CDC. Update: Recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding use of CSL Seasonal Influenza Vaccine (Afluria) in the United States during 2010-2011. Available at http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5931a4.htm.
7. Reportable Events Table. Available at; 2011 [accessed 23.01.11]. http://vaers.hhs.gov/resources/VAERS_Table_of_Reportable_Events_Following_Vaccination.pdf.
8. Medical Dictionary for Regulatory Activities Maintenance and Support Services Organization. Available at; 2011 [accessed 26.02.11]. http://www.meddramsso.com/.
9. DuMouchel W. Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system. Am Stat 1999, 53:177-190.
10. Szarfman A., Machado S.G., O'Neill R.T. Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database. Drug Saf 2002, 25(6):381-392.
11. Bonhoeffer J., Kohl K., Chen R., Duclos P., Heijbel H., Heininger U., et al. The Brighton Collaboration: addressing the need for standardized case definitions of adverse events following immunization (AEFI). Vaccine 2002, 21(December (3-4)):298-302.
12. Bonhoeffer J., Menkes J., Gold M.S., de Souza-Brito G., Fisher M.C., Halsey N., et al. Generalized convulsive seizure as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation. Brighton Collaboration Seizure Working Group. Vaccine 2004, 22(January (5-6)):557-562.
13. U.S. National Vaccine Plan. Available at; 2011 [accessed May 01.05.11]. http://www.hhs.gov/nvpo/vacc_plan/.
14. Report of CIOMS Working Group VIII. Practical Aspects of Signal Detection in Pharmacovigilence. Geneva 2010.
15. Shinnar S., Glauser T. Febrile seizures. J Child Neurol 2002, 17(Supp 1):S44-S52.
16. http://www.cdc.gov/vaccines/recs/schedules/downloads/child/mmwr-child-schedule.pdf.
17. Barlow W.E., Davis R.L., Glasser J.W., Rhodes P.H., Thompson R.S., Mullooly J.P., et al. The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. N Engl J Med 2001, 345:656-661.
18. Kohl K.S., Magnus M., Ball R., Halsey N., Shadomy S., Farley T.A. Applicability, reliability, sensitivity, and specificity of six Brighton Collaboration standardized case definitions for adverse events following immunization. Vaccine 2008, 26(November (50)):6349-6360.
19. FDA. Fluzone Vaccine Safety: FDA and CDC Update on Fluzone Influenza Vaccine and VAERS Reports of Febrile Seizures in Children, January 20, 2011. Available at; 2011 [accessed 23.01.11]. http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/VaccineSafety/ucm240037.htm.
20. Tse A., Tseng H.F., Greene S., Vellozzi C., Lee G. Identification and evaluation of risk for seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011. Vaccine 2011, on behalf of the VSD Rapid Cycle Analysis Influenza Working Group, [concurrent submission].